ALS | Hadassah International

Kadimastem Announces Promising Interim Results in ALS Clinical Trial

Kadimastem Ltd, a clinical stage cell therapy company, has announced promising interim results with cohort A of its Phase 1/2a clinical trial for the treatment of patients with Amyotrophic Lateral…

ALS Research

Positive Attitude? Less Pain for ALS Patients

ALS Research

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

ALS Research

BrainStorm currently conducts Second Phase ALS Studies at Hadassah – Test Results expected by July 2016

Hadassah Hospital

A Wonderful Beginning to the New Year for Hadassah!

ALS Research

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

ALS Research

Israeli specialists recommend that bearers of the “breast cancer gene” have their Ovaries removed at a young age

ALS Research

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

Ophthalmology

Professor Eitan Kerem Talks About How Hadassah Repairs Blindness and Heals Damaged Hearts While on a Visit to Mexico

ALS Research

Stem Cell Trial at Hadassah Reveals Significant Positive Results for ALS Patients

Stem Cell Research

New Hadassah Medical Center Clinical Trial Data Show Promise for Stem Cell Therapy in Treating ALS

ALS Research

FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology

Stem Cell Research

BrainStorm Stem Cell Technology Administered at Hadassah Yields Major Therapeutic Results in Patient with ALS and Myasthenia Gravis

ALS Research

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

Genetics

Creating the Medicine of the Future: Hadassah’s Goldyne Savad Institute of Gene Therapy

ALS Research

BrainStorm Stem Cell Therapy for ALS is Fast-Tracked to New Phase

ALS Research

New Trial Drug Cures Patient with ALS

ALS Research

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

ALS Research

Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells

ALS Research

Hadassah International

Kadimastem Announces Promising Interim Results in ALS Clinical Trial

Kadimastem Announces Promising Interim Results in ALS Clinical Trial

Positive Attitude? Less Pain for ALS Patients

Hadassah and Kadimastem Co-Design Embryonic Stem Cell Protocol for ALS Clinical Trial

BrainStorm currently conducts Second Phase ALS Studies at Hadassah – Test Results expected by July 2016

A Wonderful Beginning to the New Year for Hadassah!

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

Israeli specialists recommend that bearers of the “breast cancer gene” have their Ovaries removed at a young age

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

Professor Eitan Kerem Talks About How Hadassah Repairs Blindness and Heals Damaged Hearts While on a Visit to Mexico

Stem Cell Trial at Hadassah Reveals Significant Positive Results for ALS Patients

New Hadassah Medical Center Clinical Trial Data Show Promise for Stem Cell Therapy in Treating ALS

FDA Approves Multi-Center US Clinical Trials to Treat ALS with Israel Stem Cell Technology

BrainStorm Stem Cell Technology Administered at Hadassah Yields Major Therapeutic Results in Patient with ALS and Myasthenia Gravis

ALS Stem Cell Trial Yielding “Impressively Positive” Findings

Creating the Medicine of the Future: Hadassah’s Goldyne Savad Institute of Gene Therapy

BrainStorm Stem Cell Therapy for ALS is Fast-Tracked to New Phase

New Trial Drug Cures Patient with ALS

Hadassah Clinical Trial Reveals Safety and Efficacy of Stem Cell Technology in Treating ALS

Hadassah’s Multiple Sclerosis Center: A Global Leader in Treating MS with Stem Cells

Hadassah Receives $300,000 Grant for Stem Cell Research